ATE281162T1 - Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose - Google Patents
Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralskleroseInfo
- Publication number
- ATE281162T1 ATE281162T1 AT99936702T AT99936702T ATE281162T1 AT E281162 T1 ATE281162 T1 AT E281162T1 AT 99936702 T AT99936702 T AT 99936702T AT 99936702 T AT99936702 T AT 99936702T AT E281162 T1 ATE281162 T1 AT E281162T1
- Authority
- AT
- Austria
- Prior art keywords
- lateral sclerosis
- amyotrophic lateral
- treatment
- production
- medicinal product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9810187A FR2782008B1 (fr) | 1998-08-07 | 1998-08-07 | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique |
| PCT/FR1999/001948 WO2000007592A1 (fr) | 1998-08-07 | 1999-08-06 | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE281162T1 true ATE281162T1 (de) | 2004-11-15 |
Family
ID=9529516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99936702T ATE281162T1 (de) | 1998-08-07 | 1999-08-06 | Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6524629B1 (de) |
| EP (1) | EP1102586B1 (de) |
| JP (1) | JP4510289B2 (de) |
| AT (1) | ATE281162T1 (de) |
| AU (1) | AU5170499A (de) |
| CA (1) | CA2340021C (de) |
| DE (1) | DE69921662T2 (de) |
| ES (1) | ES2230873T3 (de) |
| FR (1) | FR2782008B1 (de) |
| NO (1) | NO327733B1 (de) |
| PT (1) | PT1102586E (de) |
| WO (1) | WO2000007592A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2785808B1 (fr) * | 1998-11-13 | 2002-12-06 | Aventis Laboratoire | Association riluzole et alpha-tocopherol |
| FR2827518B1 (fr) * | 2001-07-17 | 2005-07-08 | Sod Conseils Rech Applic | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie |
| JP4528490B2 (ja) * | 2002-06-25 | 2010-08-18 | 和光化学株式会社 | ギンコライド−ａを含有する抗不安剤 |
| WO2004074024A2 (en) | 2003-02-19 | 2004-09-02 | Pilkington North America, Inc. | Powered slider drive interface and drive assembly |
| RU2005137567A (ru) * | 2003-05-02 | 2006-04-27 | Джорджтаун Юниверсити (Us) | Экстракт гинкго билоба как средство для лечения терапевтически индуцированной нейротоксичности |
| WO2006004386A1 (es) * | 2004-07-02 | 2006-01-12 | Rojas Castaneda Patricia | Uso de un extracto del ginkgo biloba para preparar una medicina para tratar la enfermedad de parkinson |
| JP2009510457A (ja) * | 2005-09-30 | 2009-03-12 | キナメッド・インコーポレイテッド | バイオマーカーとしての微小管合成 |
| JP5297201B2 (ja) * | 2006-01-05 | 2013-09-25 | キナメッド・インコーポレイテッド | 運動ニューロン疾患の調節物質を用いる治療方法および組成物 |
| FR2904222A1 (fr) | 2006-07-27 | 2008-02-01 | Sod Conseils Rech Applic | Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales |
| AU2009248971B2 (en) * | 2008-05-21 | 2015-04-30 | Kinemed, Inc. | Compositions and methods of treatment using modulators of motoneuron diseases |
| GB0922064D0 (en) | 2009-12-17 | 2010-02-03 | Pilkington Group Ltd | Soda lime silica glass composition |
| WO2013108926A1 (en) * | 2012-01-17 | 2013-07-25 | Kyoto University | Prophylactic and therapeutic drug for amyotrophic lateral sclerosis and method of screening therefor |
| WO2016114655A1 (en) * | 2015-01-12 | 2016-07-21 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
| WO2017065602A1 (en) * | 2015-10-13 | 2017-04-20 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
| CN108096243B (zh) * | 2017-11-24 | 2020-05-29 | 江苏康缘药业股份有限公司 | 银杏内酯组合物的医药用途 |
| CN110893183A (zh) * | 2018-09-13 | 2020-03-20 | 成都百裕制药股份有限公司 | 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3338995A1 (de) * | 1983-10-27 | 1985-05-09 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Bilobalid enthaltende arzneimittel |
| DE3940094A1 (de) * | 1989-12-04 | 1991-06-06 | Montana Ltd | Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel |
| DE4328374A1 (de) * | 1993-08-24 | 1995-03-02 | Deinlein Kalb Hans | Neue Verwendung eines Extraktes aus den Blättern von Ginkgo biloba |
| JP3468526B2 (ja) * | 1995-10-26 | 2003-11-17 | サノフィーサンテラボ | 筋萎縮性側索硬化症治療薬調製のための１−（２−ナフタ−２−イルエチル）−４−（３−トリフルオロメチルフェニル）−１，２，３，６−テトラヒドロピリジンの使用 |
-
1998
- 1998-08-07 FR FR9810187A patent/FR2782008B1/fr not_active Expired - Fee Related
-
1999
- 1999-08-06 DE DE69921662T patent/DE69921662T2/de not_active Expired - Lifetime
- 1999-08-06 AT AT99936702T patent/ATE281162T1/de active
- 1999-08-06 WO PCT/FR1999/001948 patent/WO2000007592A1/fr active IP Right Grant
- 1999-08-06 PT PT99936702T patent/PT1102586E/pt unknown
- 1999-08-06 JP JP2000563277A patent/JP4510289B2/ja not_active Expired - Fee Related
- 1999-08-06 AU AU51704/99A patent/AU5170499A/en not_active Abandoned
- 1999-08-06 US US09/744,464 patent/US6524629B1/en not_active Expired - Lifetime
- 1999-08-06 EP EP99936702A patent/EP1102586B1/de not_active Expired - Lifetime
- 1999-08-06 ES ES99936702T patent/ES2230873T3/es not_active Expired - Lifetime
- 1999-08-06 CA CA002340021A patent/CA2340021C/fr not_active Expired - Fee Related
-
2001
- 2001-02-06 NO NO20010627A patent/NO327733B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4510289B2 (ja) | 2010-07-21 |
| NO20010627L (no) | 2001-02-06 |
| DE69921662T2 (de) | 2005-10-20 |
| NO20010627D0 (no) | 2001-02-06 |
| EP1102586B1 (de) | 2004-11-03 |
| US6524629B1 (en) | 2003-02-25 |
| NO327733B1 (no) | 2009-09-14 |
| CA2340021C (fr) | 2009-09-15 |
| FR2782008B1 (fr) | 2003-04-25 |
| FR2782008A1 (fr) | 2000-02-11 |
| EP1102586A1 (de) | 2001-05-30 |
| PT1102586E (pt) | 2005-02-28 |
| CA2340021A1 (fr) | 2000-02-17 |
| WO2000007592A1 (fr) | 2000-02-17 |
| DE69921662D1 (de) | 2004-12-09 |
| JP2002522387A (ja) | 2002-07-23 |
| ES2230873T3 (es) | 2005-05-01 |
| AU5170499A (en) | 2000-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69921662D1 (de) | Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose | |
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| ATE299022T1 (de) | Verwendung von cyclopamine zur herstellung eines arzneimittels zur behandlung von psoriasis | |
| ATE120961T1 (de) | Konzentrate von aktiven verbindungen und kombinationen von aktiven verbindungen, ihre verfahren zur herstellung und arzneimittel, die die konzentrate oder die kombinationen enthalten. | |
| ATE330593T1 (de) | Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen | |
| SE9401406L (sv) | Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma | |
| DE59410052D1 (de) | Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids | |
| ATE139445T1 (de) | Verwendung von zinkionen zur behandlung der periodontitis | |
| ATE318133T1 (de) | Verwendung von stearidonsäure zur herstellung eines arzneimittels für die behandlung oder vorbeugung von krebs | |
| HK1069327A1 (en) | Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia | |
| ATE219670T1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
| DE59508961D1 (de) | Verwendung von weihrauch zur behandlung der alzheimer-krankheit | |
| ATE274349T1 (de) | Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs | |
| ATE246518T1 (de) | Egr-1 zur herstellung eines medikamentes zur behandlung von wunden | |
| DE60002226D1 (de) | Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte | |
| DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
| ATE309817T1 (de) | Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs | |
| DE69423577D1 (de) | Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen. | |
| ATE135220T1 (de) | Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose | |
| DE69733169D1 (de) | Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs | |
| DE69805096D1 (de) | Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| ATE229803T1 (de) | Verwendung eines flavonoid enthaltenden extraktes der planze euphorbia prostrata zur herstellung eines medikamentes zur behandlung von anoraktalen oder kolonbeschwerden | |
| DE69918339D1 (de) | Pharmazeutische zusammensetzungen die selegilin und ginkgo biloba extrakt enthalten zur behandlung von demenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1102586 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |